Company overview
Basic information
Company name
Westmeda, MB
Company code
305929691
Registered address
Vilnius, Treniotos g. 2-12, LT-08121
Registration date
2021-11-04
Company age: 4 y. 11 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Sports and recreation education
Ownership form
Private without foreign capital
MB Westmeda
Company code: 305929691
Address: Vilnius, Treniotos g. 2-12, LT-08121
Description
This description was generated by artificial intelligence.
Westmeda, MB (company code 305929691) is an operational private small partnership registered in 2021. It operates in the national private non-financial companies sector and is governed by a CEO only. The company is privately owned, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Its main activity, under EVRK code Q.85.51.00, is Sports and recreation education.
The company is based in Vilnius, Treniotos g. 2-12, LT-08121, Vilniaus m. sav., Vilniaus apskr. Financially, revenue increased from EUR 28.2K in 2023 to EUR 31.8K in 2024. Net profit decreased from EUR 19.4K to EUR 4.7K, while the profit margin fell from 68.9% to 14.8%. Equity rose to EUR 24.2K in 2024, total assets reached EUR 42.1K, and liabilities were EUR 17.9K. The business remained very small, with an average of 1 employee in both 2023 and 2024.
The company is based in Vilnius, Treniotos g. 2-12, LT-08121, Vilniaus m. sav., Vilniaus apskr. Financially, revenue increased from EUR 28.2K in 2023 to EUR 31.8K in 2024. Net profit decreased from EUR 19.4K to EUR 4.7K, while the profit margin fell from 68.9% to 14.8%. Equity rose to EUR 24.2K in 2024, total assets reached EUR 42.1K, and liabilities were EUR 17.9K. The business remained very small, with an average of 1 employee in both 2023 and 2024.
Download a detailed company report
Make confident decisions with all the information about Westmeda, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.